Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.
The aim of the trial is to fully understand the benefits of a PARP inhibitor versus standard chemotherapy for BRCA-positive women who have had two previous treatments. Drugs involved in this trial: rucaparib, a PARP inhibitor paclitaxel, a standard chemotherapy drug carboplatin or cisplatin, standard chemotherapy drugs. Women in t…
The main purpose of conducting the trial is to: determine the safety of combining cediranib, a VEGF inhibitor, with paclitaxel a weekly chemotherapy regime find out how well the treatment works in terms of shrinking the cancer and preventing bowel obstruction. If the cancer responds to this treatment then after the course of paclitaxel…
This study is looking at using a new drug called TAK228 (new drug) in combination with paclitaxel (a chemotherapy drug) to see if it is a more effective way of treating ovarian cancer. If you were to take part in this trial you would be randomised to receive either paclitaxel on its own or paclitaxel and TAK228. You would be monitored throughout…
This study collects information about people who have inherited faulty cancer genes. Inheriting a faulty gene means that a person is at a higher risk of developing certain cancers. A fault in the BRCA1 or BRCA2 genes means that a person is more likely to develop cancers of the breast, ovary or prostate. As well as the BRCA1 and BRCA2 genes, we n…
The FORECEE (4C) research project is a new major study investigating the risk of breast, ovarian, womb and cervical cancer. Women who volunteer to take part in the study will be asked to donate the following samples: A blood sample A cheek swab A cervical smear sample Surplus healthy or diseased tissue – if you opt for risk-reducing sur…
This trial looks to answer the question as to whether two different types of anti-cancer drugs, given as maintenance treatment are: safe effective well-tolerated Maintenance treatment refers to drugs that are given to try to prevent or delay the cancer's return after it has responded to chemotherapy. Drugs used in this trial: …
Sign up to receive emails from Target Ovarian Cancer, including our monthly newsletter, and be the first to hear about campaigns, upcoming events and fundraising inspiration.
Sign up
